| Angela L Ladenburg, ARNP | |
|
4707 S 19th St Ste 130, Tacoma, WA 98405-1151 | |
| (253) 752-7705 | |
| (253) 752-0113 |
| Full Name | Angela L Ladenburg |
|---|---|
| Gender | Female |
| Speciality | Nurse Practitioner |
| Location | 4707 S 19th St Ste 130, Tacoma, Washington |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1508048182 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207N00000X | Dermatology | AP30007974 (Washington) | Secondary |
| 363L00000X | Nurse Practitioner | AP30007974 (Washington) | Primary |
| Entity Name | Eric O Rasmussen |
|---|---|
| Entity Type | Practitioner - Dermatology |
| Entity Identifiers | NPI Number: 1467423376 PECOS PAC ID: 1153211453 Enrollment ID: I20100708000267 |
News Archive
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.
Hoag Orthopedic Institute, one of the largest providers of orthopedic care in the nation, recently attended The International Consortium for Health Outcomes Measurement value-based health care conference in London as a sponsoring partner, to present the international standard set for the measurement of hip and knee osteoarthritis outcomes that matter most to patients.
In a study that looked at racial differences in outcomes of COVID-19 patients admitted to the intensive care unit, researchers at Henry Ford Hospital in Detroit found that patients of color had a lower 28-day mortality than white patients.
According to experts a simple DNA test for Down syndrome could save nearly all pregnant women from invasive tests like amniocentesis. Usually 3% to 5% of pregnant women in the UK or some 30,000 women have to undergo invasive tests like amniocentesis that increases the risk of miscarriage to 1%. The new DNA blood test could bring this down to 0.1%, according to a study in the British Medical Journal.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Angela L Ladenburg, ARNP 4700 Point Fosdick Dr Nw Ste 219, Gig Harbor, WA 98335-1706 Ph: (253) 851-7733 | Angela L Ladenburg, ARNP 4707 S 19th St Ste 130, Tacoma, WA 98405-1151 Ph: (253) 752-7705 |
News Archive
3SBio Inc., a leading China-based biotechnology company focused on researching, developing, manufacturing and marketing biopharmaceutical products, today announced a collaboration and license agreement with Panacor Bioscience Ltd. to develop and commercialize its Nephoxil(R) pharmaceutical product for the treatment of hyperphosphatemia in China.
Hoag Orthopedic Institute, one of the largest providers of orthopedic care in the nation, recently attended The International Consortium for Health Outcomes Measurement value-based health care conference in London as a sponsoring partner, to present the international standard set for the measurement of hip and knee osteoarthritis outcomes that matter most to patients.
In a study that looked at racial differences in outcomes of COVID-19 patients admitted to the intensive care unit, researchers at Henry Ford Hospital in Detroit found that patients of color had a lower 28-day mortality than white patients.
According to experts a simple DNA test for Down syndrome could save nearly all pregnant women from invasive tests like amniocentesis. Usually 3% to 5% of pregnant women in the UK or some 30,000 women have to undergo invasive tests like amniocentesis that increases the risk of miscarriage to 1%. The new DNA blood test could bring this down to 0.1%, according to a study in the British Medical Journal.
› Verified 9 days ago